Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Sanofi
DescriptionCombination of SAR405838, a small molecule inhibitor of p53-MDM2 protein-protein interactions and MSC1936369B, an inhibitor of MEK1 and MEK2
Molecular Target MAP kinase kinase 1 (MAP2K1) (MEK1) ; MAP kinase kinase 2 (MAP2K2) (MEK2)
Mechanism of ActionMEK inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today